Nanobiotix (NASDAQ:NBTX) Shares Gap Up – What’s Next?

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $17.70, but opened at $18.77. Nanobiotix shares last traded at $19.9770, with a volume of 55,641 shares.

Analyst Ratings Changes

A number of equities analysts have commented on NBTX shares. Leerink Partners set a $14.00 target price on shares of Nanobiotix in a report on Thursday, September 18th. HC Wainwright reaffirmed a “buy” rating on shares of Nanobiotix in a research report on Tuesday. Wall Street Zen raised shares of Nanobiotix to a “hold” rating in a research report on Saturday, October 25th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nanobiotix in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Nanobiotix has a consensus rating of “Hold” and a consensus target price of $11.00.

Nanobiotix Stock Performance

The business’s 50-day simple moving average is $16.57 and its 200-day simple moving average is $9.17.

About Nanobiotix

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.